More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Photo Release: Dr. Murad A. Sunalp, Internationally Recognized Ophthalmology Expert, Joins AXIM Biotechnologies Advisory Board

Photo Release: Dr. Murad A. Sunalp, Internationally Recognized Ophthalmology Expert, Joins AXIM Biotechnologies Advisory Board

by adminAdrianRamirez | Jan 20, 2015 | Axim Biotechnologies, Company News, Press Releases

Leading Industrial Hemp Biosciences Company Sets Sites on Furthering Ophthalmology-Focused Cannabinoid Research and Development, Expands R&D Portfolio With Cannabinoid-Based Ophthalmological Products NEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) — AXIM...

Photo Release: AXIM Biotechnologies Announces Netherlands Land Deal for Manufacturing Site

by adminAdrianRamirez | Nov 20, 2014 | Axim Biotechnologies, Company News, Press Releases

Company’s Global Innovative Hemp-Based Products Manufacturing Facility Planned in Almere, The Netherlands NEW YORK, Nov. 20, 2014 (GLOBE NEWSWIRE) — AXIM Biotechnologies (OTC:AXIM) brings to market global innovative solutions that set the “green...
Photo Release — Top Global Experts Join AXIM Biotechnologies Advisory Board

Photo Release — Top Global Experts Join AXIM Biotechnologies Advisory Board

by adminAdrianRamirez | Nov 6, 2014 | Axim Biotechnologies, Company News, Press Releases

‘Invaluable Experience’ Set to Bolster Company’s Proposed Clinical Trials and Product Development NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) — AXIM Biotechnologies (OTC:AXIM) is setting the “green standard” in the industrial hemp...
AXIM Biotechnologies Delivers Net Negative Carbon Footprint With All-Natural Industrial Hemp

AXIM Biotechnologies Delivers Net Negative Carbon Footprint With All-Natural Industrial Hemp

by adminAdrianRamirez | Oct 30, 2014 | Axim Biotechnologies, Company News, Media Coverage

Company’s Proprietary Industrial Hemp Development, Production, and Delivery Methods Innovate Global Nutraceutical and Pharmaceutical Markets/em> NEW YORK, Oct. 30, 2014 (GLOBE NEWSWIRE) — AXIM Biotechnologies (OTC:AXIM) proudly announces its strategic...
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.